Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respiratory, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. It exports its products to approximately 90 countries across Asia, North America, Europe, Africa, South America, and Australia. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of SUNP-NS would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1996) — listing | $7,473,089 163.2× | $10,509,181 157.7× |
| Year 6 (2001) | $1,070,464 28.2× | $1,523,838 27.4× |
| Year 11 (2006) | $211,659 7.0× | $314,139 7.0× |
| Year 16 (2011) | $75,980 3.3× | $112,683 3.3× |
| Year 21 (2016) | $40,461 2.6× | $59,891 2.6× |
| Year 26 (2021) | $13,563 1.7× | $20,058 1.7× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Mumbai, Maharashtra, India
Popular scenarios with SUNPHARMA
For illustration only — not investment advice. Past performance is not indicative of future results.